AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Thursday, July 18, 2019

In The News

Digital health is progressing at an astounding speed, aided by artificial intelligence (AI) technologies. Clinical labs and other healthcare providers face the ongoing challenge of understanding, navigating, and using these tools judiciously, with an eye toward protecting patients and avoiding liability.

AACC Alert

Whether you’re a first-time attendee or veteran of the AACC Annual Scientific Meeting & Clinical Lab Expo, AACC Artery offers plenty of opportunities to gear up for the 71st conclave in Anaheim, California.

Practice Management

A meta-analysis of studies examining testing algorithms for Clostridioides difficile infection (CDI) recommended nucleic amplification tests (NAAT) as a best practice in three key clinical scenarios, either alone or in combination with other testing modalities, for identifying the C. difficile organism or toxin.
Individuals with HIV have a significantly higher risk of cardiovascular disease (CVD), but clinicians haven’t always understood this connection. In a new scientific statement, the American Heart Association (AHA) offers some causal explanations for the HIV/CVD relationship and proposes a pragmatic approach to assessing risk for and preventing atherosclerotic CVD…

World View

Researchers and clinicians alike have placed stock in procalcitonin (PCT) testing for differentiating between infectious and noninfectious disease and for stratifying morbidity and mortality risk. However, more evidence about the limitations of this biomarker has become available, prompting three researchers to discuss in a review PCT’s role in the work-up…